Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning

Leuk Lymphoma. 2011 Feb;52(2):321-4. doi: 10.3109/10428194.2010.529205.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Busulfan / administration & dosage*
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Injections, Intravenous
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Middle Aged
  • Myeloablative Agonists / administration & dosage
  • Myelodysplastic Syndromes / therapy*
  • Retrospective Studies
  • Survival Rate
  • Transplantation Conditioning*
  • Transplantation, Homologous
  • Treatment Outcome
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • Myeloablative Agonists
  • Vidarabine
  • Busulfan
  • fludarabine